Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

AI Alliance Launches to Advance Open, Safe, Responsible AI (2023-12-05)
IBM and Meta Launch the AI Alliance in collaboration with over 50 Founding Members and Collaborators globally including AMD, Anyscale, CERN, Cerebras, Cleveland Clinic, Cornell University, Dartmouth, Dell Technologies, EPFL, ETH, Hugging Face, Imperial College Lond...
Refeyn Launches KaritroMP Macro Mass Photometer (2023-11-30)
New macro mass photometer can assess the stability, quality, and purity of adenovirus and lentivirus vectors in just minutes Refeyn, a leader in mass photometry technology, announces the launch of its macro mass photometry platform, KaritroMP. This new benchto...
Syncona to Acquire Freeline Therapeutics in Going-Private (2023-11-22)
> Freeline shareholders to receive $6.50 per American Depositary Share, a 51% premium over closing price prior to announcement of Syncona’s initial proposal on October 18, in an all-cash transaction > Based on extensive evaluation of available strategic and fina...
Merck to Acquire Caraway Therapeutics for up to $610m (2023-11-21)
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. announced today that the companies have entered i...
Recipharm: Marc Funk Moves to BoD; Greg Behar New CEO (2023-11-21)
Recipharm, a leading, global player in the pharmaceutical CDMO industry, announces today the appointment of Greg Behar as Chief Executive Officer. Marc Funk, who successfully led Recipharm into its next phase of growth, will join the Board of Directors, where he wi...
Flagship Pioneering Unveils Quotient Therapeutics (2023-11-21)
Flagship Pioneering, the bioplatform innovation company, today unveiled Quotient Therapeutics, a company pioneering somatic genomics, the study of genetic variation at the cellular level, to discover therapeutics informed by new links between genes and disease. Fla...
eXmoor Appoints Matthew Paterson as Chief Commercial Officer (2023-11-16)
New CCO to apply experience growing US and UK business to support eXmoor’s expansion eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, announced the hiring of Matthew Paterson as the company’s first Chief Commercial Officer, to...
T-Therapeutics Raises £48m Series A Round (2023-11-15)
> Fundraise led by Sofinnova Partners, F-Prime Capital, Digitalis Ventures and Cambridge Innovation Capital with participation from Sanofi Ventures and the University of Cambridge Venture Fund > Unique transgenic mouse platform harnesses natural power of T cells...
Glox Therapeutics Secures £4.3M Seed Funding (2023-11-14)
> Investment to accelerate development of a novel class of targeted high-potency bacteriocins against specific antimicrobial-resistant pathogens > Spin-out from the Universities of Glasgow and Oxford > Funding led by Boehringer Ingelheim Venture Fund and Sco...
Autifony & Jazz Pharmaceuticals: up to $770.5m Agreement (2023-11-14)
> Total Deal Value of Up to $770.5 million including Upfront Payment and Potential Milestone Payments > Autifony Eligible to Receive Royalties on Future Net Sales Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharm...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture Berlin Partner Voices from HealthCapital Charpentier 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)